Japan · Delayed Price · Currency is JPY Medikit Statistics
Total Valuation
Medikit has a market cap or net worth of JPY 41.84 billion. The enterprise value is 21.86 billion.
| Market Cap | 41.84B |
| Enterprise Value | 21.86B |
Important Dates
The last earnings date was Friday, August 7, 2026.
| Earnings Date | Aug 7, 2026 |
| Ex-Dividend Date | Sep 29, 2026 |
Share Statistics
Medikit has 14.48 million shares outstanding. The number of shares has decreased by -1.06% in one year.
| Current Share Class | 14.48M |
| Shares Outstanding | 14.48M |
| Shares Change (YoY) | -1.06% |
| Shares Change (QoQ) | -0.05% |
| Owned by Insiders (%) | 7.96% |
| Owned by Institutions (%) | 17.00% |
| Float | 4.55M |
Valuation Ratios
The trailing PE ratio is 13.39.
| PE Ratio | 13.39 |
| Forward PE | n/a |
| PS Ratio | 1.73 |
| PB Ratio | 0.90 |
| P/TBV Ratio | 0.96 |
| P/FCF Ratio | 32.36 |
| P/OCF Ratio | 8.84 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.29, with an EV/FCF ratio of 16.91.
| EV / Earnings | 6.97 |
| EV / Sales | 0.90 |
| EV / EBITDA | 3.29 |
| EV / EBIT | 4.84 |
| EV / FCF | 16.91 |
Financial Position
The company has a current ratio of 6.52, with a Debt / Equity ratio of 0.00.
| Current Ratio | 6.52 |
| Quick Ratio | 5.04 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | 0.01 |
| Interest Coverage | 644.86 |
Financial Efficiency
Return on equity (ROE) is 6.86% and return on invested capital (ROIC) is 11.43%.
| Return on Equity (ROE) | 6.86% |
| Return on Assets (ROA) | 5.41% |
| Return on Invested Capital (ROIC) | 11.43% |
| Return on Capital Employed (ROCE) | 9.44% |
| Weighted Average Cost of Capital (WACC) | 4.80% |
| Revenue Per Employee | 24.40M |
| Profits Per Employee | 3.16M |
| Employee Count | 994 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 2.90 |
Taxes
In the past 12 months, Medikit has paid 1.58 billion in taxes.
| Income Tax | 1.58B |
| Effective Tax Rate | 33.51% |
Stock Price Statistics
The stock price has increased by +14.88% in the last 52 weeks. The beta is 0.10, so Medikit's price volatility has been lower than the market average.
| Beta (5Y) | 0.10 |
| 52-Week Price Change | +14.88% |
| 50-Day Moving Average | 2,813.68 |
| 200-Day Moving Average | 2,893.80 |
| Relative Strength Index (RSI) | 64.45 |
| Average Volume (20 Days) | 2,000 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medikit had revenue of JPY 24.26 billion and earned 3.14 billion in profits. Earnings per share was 215.87.
| Revenue | 24.26B |
| Gross Profit | 9.25B |
| Operating Income | 4.51B |
| Pretax Income | 4.72B |
| Net Income | 3.14B |
| EBITDA | 6.64B |
| EBIT | 4.51B |
| Earnings Per Share (EPS) | 215.87 |
Balance Sheet
The company has 19.99 billion in cash and 17.00 million in debt, with a net cash position of 19.98 billion or 1,379.81 per share.
| Cash & Cash Equivalents | 19.99B |
| Total Debt | 17.00M |
| Net Cash | 19.98B |
| Net Cash Per Share | 1,379.81 |
| Equity (Book Value) | 46.65B |
| Book Value Per Share | 3,221.77 |
| Working Capital | 27.76B |
Cash Flow
In the last 12 months, operating cash flow was 4.73 billion and capital expenditures -3.44 billion, giving a free cash flow of 1.29 billion.
| Operating Cash Flow | 4.73B |
| Capital Expenditures | -3.44B |
| Depreciation & Amortization | 2.13B |
| Net Borrowing | n/a |
| Free Cash Flow | 1.29B |
| FCF Per Share | 89.31 |
Margins
Gross margin is 38.11%, with operating and profit margins of 18.61% and 12.93%.
| Gross Margin | 38.11% |
| Operating Margin | 18.61% |
| Pretax Margin | 19.45% |
| Profit Margin | 12.93% |
| EBITDA Margin | 27.37% |
| EBIT Margin | 18.61% |
| FCF Margin | 5.44% |
Dividends & Yields
This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 3.51%.
| Dividend Per Share | 100.00 |
| Dividend Yield | 3.51% |
| Dividend Growth (YoY) | 5.26% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 1.06% |
| Shareholder Yield | 4.57% |
| Earnings Yield | 7.50% |
| FCF Yield | 3.09% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 30, 2020. It was a forward split with a ratio of 2.
| Last Split Date | Mar 30, 2020 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Medikit has an Altman Z-Score of 6.36 and a Piotroski F-Score of 6.
| Altman Z-Score | 6.36 |
| Piotroski F-Score | 6 |